BGIM
LLY icon

Boussard & Gavaudan Investment Management’s Eli Lilly LLY Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,000
Closed -$38.7M – 80
2024
Q4 		$38.7M Buy
+50,000
New +$41.4M 3.23% 9
2024
Q1 		– Sell
-3,578
Closed -$2.09M – 98
2023
Q4 		$2.09M Buy
+3,578
New +$2.09M 0.41% 43

Other funds holding LLY

PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Boussard & Gavaudan Investment Management's LLY Position: Q1 2025 in Review

Boussard & Gavaudan Investment Management sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 50,000 shares — an estimated $38.7M sold.

Boussard & Gavaudan Investment Management first reported a position in LLY in Q4 2023 and held it in 2 quarters. The position peaked at $38.7M in Q4 2024. 3,921 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Boussard & Gavaudan Investment Management reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 50,000 Eli Lilly shares in Q1 2025, an estimated $38.7M.
  • Boussard & Gavaudan Investment Management first reported a position in Eli Lilly in Q4 2023 and held it in 2 quarters.
  • Boussard & Gavaudan Investment Management's Eli Lilly position peaked at $38.7M in Q4 2024.
  • 3,921 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q1 2025, filed 15 May 2025.